| State: | Kentucky |
|---|---|
| Address: | 4350 Brownsboro Rd, Louisville, KY 40207 |
| Zip code: | 40207 |
| Phone: | (502) 893-4570 |
| Website: | http://www.nxpharmagen.com/contact-us |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about NX PharmaGen, use the form below and your opinion, advice or comment will appear in this space.
The phone number for NX PharmaGen is (502) 893-4570.
NX PharmaGen is located at 4350 Brownsboro Rd, Louisville, KY 40207
The website (URL) for NX PharmaGen is: http://www.nxpharmagen.com/contact-us
NX PharmaGen's groundbreaking technologies are paving the way for patients to realize the promise of personalized medicine in cancer, prenatal care, and other conditions. The next generation of medical care is dawning, and the tools that NX PharmaGen is developing may play a key role in solving the...
NX Pharmagen Inc. Industry: Other Health Care CIK Number: 0001508691 IRS Number: 272135794 Address: 4350 BROWNSBORO ROAD SUITE 110 LOUISVILLE 40207 Phone number: 502-893-4570. Directors and Executives of NX Pharmagen Inc.
NX PharmaGen General Information. Description. Developer of molecular diagnostics and tumor imaging platform intended to diagnose preterm birth, cancer, and other diseases. Louisville, KY 40207. United States. +1 (502) 000-0000. Want detailed data on 2M+ companies?
Последние твиты от NX PharmaGen (@NXPharmaGen). We are developing blood-based diagnostic tests which exploit biomarkers found within circulating exosomes, for prenatal and cancer applications. NX PharmaGen начал(а) читать.
NX PharmaGen's business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company's lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield
NX PharmaGen has developed a novel molecular diagnostics platform for preterm birth, cancer and other diseases. The NeXosome™ Platform enables the collection of valuable diagnostic data via the analysis of biomarker-containing microvesicles (a.k.a. exosomes) shed from placental, tumor, or...
Venture companies. NX Pharmagen Technologies. NX Pharmagen Technologies. Send request.
NX PharmaGen acquires, develops, and monetizes mature clinical-stage technologies. The company's lead program is a disruptive diagnostic technology, termed the NeXosome Platform. Through its wholly-owned subsidiary, NX Development Corp., the company has obtained options to pursue additional...
Free and open company data on New Brunswick (Canada) company NX PharmaGen Canada Inc. (company number 664576). NX PharmaGen Canada Inc. Company Number. 664576.
NX Pharmagen is a Louisville-based company founded in 02/2010. See NX Pharmagen's revenue, employees, and funding info on Owler, the world's largest community-based business insights platform. NX Pharmagen's Competitors, Revenue, Number of Employees, Funding and Acquisitions.